For press inquiries click here to contact us.
FierceBiotech
Robert Zeldin to take post at Acceleron as its CMO retires
Xconomy
Alder BioPharmaceuticals Picks Juno’s Robert Azelby for CEO
FiercePharma
Novartis’ brand-new gene therapy player AveXis will build $55M plant, hire 200
FierceBiotech
Grail’s third VC round brings funding total to $1.5B
Xconomy
ORIC Pharmaceuticals Appoints Jacob Chacko CEO
San Francisco Business Times
‘Bursting at the seams,’ this high-profile Peninsula biotech company is moving to a bigger home
FierceBiotech
Loxo RET inhibitor shines in early-phase trial
STAT
A much-needed sickle cell drug reaches a critical readout. Here’s what you need to know
CNN Money
Are you at risk for cancer? This startup CEO wants to help you find out
Please see important disclaimers in the Terms section.